Lifeboat Foundation

The name’s Peeqo. [cat blinks endlessly].

Great news for SENS Research and Rejuvenation Biotechnology.

One of the biggest highlights of the year for us has got to be Internet Entrepreneur Michael Greve committing $10 million to SENS-related research and startups. A list of some of the projects he is supporting can be found at the Forever Healthy Foundation. We are so pleased to have the support of Michael and his team in the mission to bring rejuvenation biotechnology to the world.

“In order to accelerate the access to healthy longevity for all of us we directly fund cutting-edge research on molecular and cellular repair to combat the root causes of aging and support the creation of startups turning that research into therapies for human application.” — Michael Greve.

Continue reading “Funding a Cure for Aging” »

At Quora, I occasionally role play, “Ask the expert” under the pen name, Ellery. Today, I was asked “Is it too late to get into Bitcoin and the Blockchain”.

A few other Bitcoin enthusiasts interpreted the question to mean “Is it too late to invest in Bitcoin”. But, I took to to mean “Is it too late to develop the next big application—or create a successful startup?”. This is my answer. [co-published at Quora]…

The question is a lot like asking if it is too late to get into the television craze—back in the early 1930s. My dad played a small role in this saga. He was an apprentice to Vladamir Zworykin, inventor of the cathode ray tube oscilloscope. (From 1940 until the early 2000s, televisions and computer monitors were based on the oscilloscope). So—for me—there is fun in this very accurate analogy…

John Logie Baird demonstrated his crude mechanical Televisor in 1926. For the next 8 years, hobbyist TV sets were mechanical. Viewers peeked through slots on a spinning cylinder or at an image created from edge-lit spinning platters. The legendary Howdy Doody, Lucille Ball and Ed Sullivan were still decades away.

Continue reading “Is it too late to get into Bitcoin and the Blockchain?” »

CellAge targeting senescent cells using sythetic biology! Check out their new campaign video on Lifespan.io

Check out CellAge and their approach to removing senescent cells that accumulate with age and damage tissue regeneration.

https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/

Zapping your nerves to jumpstart the blood clotting process.

Senolytics moving into human clinical trials in the next 18 months! One of the greatest pieces of biotech news of 2016.

The Silicon Valley drugmaker is part of a wave of new companies chasing after the fountain of youth.

By Caroline Chen Bloomberg

Continue reading “Anti-aging startup backed by Fidelity, Bezos raises $116 million” »

Developments in computing are driving the transformation of entire systems of production, management, and governance. In this interview Justine Cassell, Associate Dean, Technology, Strategy and Impact, at the School of Computer Science, Carnegie Mellon University, and co-chair of the Global Future Council on Computing, says we must ensure that these developments benefit all society, not just the wealthy or those participating in the “new economy”.

Why should the world care about the future of computing?

Today computers are in virtually everything we touch, all day long. We still have an image of computers as being rectangular objects either on a desk, or these days in our pockets; but computers are in our cars, they’re in our thermostats, they’re in our refrigerators. In fact, increasingly computers are no longer objects at all, but they suffuse fabric and virtually every other material. Because of that, we really do need to care about what the future of computing holds because it is going to impact our lives all day long.

Continue reading “World Economic Forum” »

A new video spotlights Positron Dynamics, a research startup investigating how to use antimatter to explore beyond the solar system.

More progress with cancer and using a similar approach to senolytics, no surprise really as cancer and senescent cell share a lot of common ground and approach that work with one may well work with the other if they are aimed at inducing apoptosis.

Apoptosis, or programmed cell death, is a rapid and irreversible process to efficiently eliminate dysfunctional cells. A hallmark of cancer is the ability of malignant cells to evade apoptosis.

Dr Luminita Paraoan, from the University’s Department of Eye and Vision Science in the Institute of Ageing and Chronic Disease, has published new findings in the British Journal of Cancer that identify the requirement of a protein called p63 for the initiation of apoptosis in UM.

Continue reading “Protein that promotes ‘cell-suicide’ could revolutionise eye cancer treatment” »